Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
Lone Simonsen, A. Kane, Jennifer Lloyd, Michel Zaffran, M. Kane
PubMed, Vol. 77, Issue 10, pp. 789–800 (1999)
10593026
Abstract
Unsafe injections are suspected to occur routinely in developing countries. We carried out a literature review to quantify the prevalence of unsafe injections and to assess the disease burden of bloodborne infections attributable to this practice. Quantitative information on injection use and unsafe injections (defined as the reuse of syringe or needle between patients without sterilization) was obtained by reviewing the published literature and unpublished WHO reports. The transmissibility of hepatitis B and C viruses and human immunodeficiency virus (HIV) was estimated using data from studies of needle-stick injuries. Finally, all epidemiological studies that linked unsafe injections and bloodborne infections were evaluated to assess the attributable burden of bloodborne infections. It was estimated that each person in the developing world receives 1.5 injections per year on average. However, institutionalized children, and children and adults who are ill or hospitalized, including those infected with HIV, are often exposed to 10-100 times as many injections. An average of 95% of all injections are therapeutic, the majority of which were judged to be unnecessary. At least 50% of injections were unsafe in 14 of 19 countries (representing five developing world regions) for which data were available. Eighteen studies reported a convincing link between unsafe injections and the transmission of hepatitis B and C, HIV, Ebola and Lassa virus infections and malaria. Five studies attributed 20-80% of all new hepatitis B infections to unsafe injections, while three implicated unsafe injections as a major mode of transmission of hepatitis C. In conclusion, unsafe injections occur routinely in most developing world regions, implying a significant potential for the transmission of any bloodborne pathogen. Unsafe injections currently account for a significant proportion of all new hepatitis B and C infections. This situation needs to be addressed immediately, as a political and policy issue, with responsibilities clearly defined at the global, country and community levels.
Topics
Field: Medicine · Subfield: Epidemiology
Keywords
Medicine,Transmission (telecommunications),Syringe,Environmental health,Developing country,Epidemiology,Post-exposure prophylaxis,Hepatitis B,Hepatitis C,Human immunodeficiency virus (HIV)
MeSH Terms
UN Sustainable Development Goals
- Partnerships for the goals (0.44)
All Available Versions
- Landing page — PubMed publishedVersion
- Landing page — Europe PMC (PubMed Central) submittedVersion
- Landing page — PubMed Central submittedVersion
- Landing page — PubMed
Citations by Year
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| 6 | 9 | 14 | 10 | 13 | 12 | 19 | 18 | 26 | 15 |
- Mutation of the mouse klotho gene leads to a syndrome resembling ageing. 1997 · 66570
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. 2009 · 45132
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. 1992 · 33990
- [Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients]. 1997 · 20864
- Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. 2021 · 19559
Continue on JournalsHub
Put what you just read into practice with these free tools.